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Abstract: The hatchability of Schistosoma haematobium eggs excreted by patients treated
with praziquantel (PZQ) was examined. The rate of hatching of the eggs excreted by the pa-
tients before treatment was 90.1%. The rates of hatching of the eggs excreted by the pa-
tients 3 hr, 24 hr and 48 hr after treatment were 25.5%, 19.2% and 29.9% respectively. In
vivo PZQ inhibits the hatching of S. haematobium eggs. The result of in vivo experiment
was strongly supported by the results of the in vitro experiments. The hatching of the eggs
exposed to PZQ at a concentration of 0.1ƒÊg/ml for one hour in vitro was inhibited.
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INTRODUCTION
Praziquantel (PZQ) is a potent antischistosomal drug. The widespread use of PZQ
reduces contamination of the environment with schistosome eggs, thus reducing transmis-
sion; in addition it reduces and prevents morbidity (WHO, 1977). The egg production of
adult female wormsceased immediately after treatment with PZQ (Andrew, 1981). However,
the eggs were excreted for months after successful treatment (McMahon and Kolstrup, 1979;
Doehring et al., 1985). It is, therefore, obligatory subject to measure ovicidal effect of PZQ.
Since 1981, a research programme on urinary schistosomiasis has been carried out at
Mwachinga village, Kwale, Kenya, under the joint sponsership of the Kenya Government and
the Japan International Cooperation Agency. The selective mass-chemotherapy with PZQ was
attempted on July 1986. The present study was designed to examine the hatchability of S.
haematobium eggs which were excreted by the patients treated with PZQ and those of eggs
exposed to PZQ in vitro.
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Hatching of eggs excreted by patients treated with PZQ:
The subjects enrolled in this study were 20 schoolchildren of Mwachinga village bet-
ween 10 and 13 years of age whose intensity of infection was moderate to severe. The
schoolchildren received a single oral dose of 40mg/kg body weight of PZQ at noon. The
urine was collected one hour before treatment, 3hr, 24 hr and 48hr after treatment. The hat-
chability of the eggs was examined immediately after collection of urine. Urine was filtered
through a nuclepore membranewith 12 fim porosity and 25 mmin diameter so as to leave
200 and more eggs on the membrane. Volume of urine filtered was then recorded. The mem-
brane was then soaked in a small bottle filled with 4 ml of distilled water and left in day
light for one hour. The hatching of the eggs was stopped by the addition of 1 ml of 10% for-
maline solution. The number of miracidium and unhatched eggs were then counted. The
number of eggs excreted by a patient was expressed by egg counts/ 10 ml of urine.
Hatching of eggs exposed to PZQ in vitro:
S. haematobium eggs were obtained from the schoolchildren at Mtsangatam Primary
School. Urine was filtered through a series of the meshes with different pore size (Nos. 5.5,
16 and 282). The eggs thus collected were washed repeatedly with Dulbecco's (-)
phosphate-buffered saline (PBS), and incubated in PBS containing various concentrations of
PZQ for different periods of time. The eggs then exposed to water after complete removal of
PZQ solution. The hatching of the eggs was stopped by the addition of 10% formaline solu-
tion. The number of micracidia and unhatched eggs were then counted.
RESULTS
Hatching of eggs excreted by patients treated with PZQ:
The geometric mean of the number of eggs excreted by 20 schoolchildren before treat-
ment was 537±4 eggs/10 ml of urine. Those of the eggs excreted 3 hr, 24 hr, and 48 hr
after treatment were 759+7, 246±3 and 363±3 eggs/10 ml of urine respectively. There was
no significant difference in the egg output during the initial 48 hr after treatment (Scheffe's
test).
When placed in water, the eggs of S. haematobium easily hatch. The rates of the hat-
ching of eggs excreted by each of 20 schoolchildren before treatment varied from 76.3% to
97.6%, with an average of 90.1%. The hatching rates of eggs excreted 3 hr, 24 hr and 48 hr
after treatment were 25.5%, 19.2% and 29.9% respectively. Fig 1. represents the change in
the percentages of hatching of the eggs excreted by each of 20 schoolchildren during the in-
itial 48 hr after treatment. Althogh individual variations exist, a definite pattern emerged
from the results is that hatching tends to decrease during the initial 24 hr after treatment
and increase slightly 48 hr after PZQ treatment.
Hatching of eggs exposd to PZQ in vitro:
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Table 1 shows the hatchability of the eggs exposed to various concentrations of PZQ
for different periods of time. The hatching rates of the eggs exposed to a high concentration
of PZQ (10 fjig/ml) for 10 minutes or more were lower than that of control eggs (chi square,
p<0.01). PZQ-inhibited hatching was depend on the concentration of PZQ and period of ex-
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Fig. 1. Hatching of eggs excreted by patients during initial 48 hr after ad-
ministration of praziquantel.
Table 1. Hatching of eggs exposed to various concentrations of praziquantel for
different periods of time in vitro
I ncubation Periodin PBS containing
Praziquantel (min)
C oncentration of Praziquantel (//g/ml)
0 0.01 0.1 1 10






96/238 (40.3) 130/304 (42.8)
225/473 (47.6) 127/294 (43.2)
80/214 (37.4) 76/218 (34.9)
116/300 (38.7) 130/331 (39.3)
93/206 (45.1) 136/272 (50.0)
129/289 (44.6) 124/354 (35.0) 90/359 (25.1)*
108/261 (41.4) 151/449 (33.6)* 41/145 (28.3)*
34/188 (18.1)* 62/260 (23.8)* 36/226 (15.9)*
70/388 (18.0)* 48/306 (15.7)* 19/253 ( 7.5)*
56/335 (16.7)* 57/307 (18.6)* 25/274 ( 9.1)*
Eggs were pre-incubated in PZQ solution. After complete removal of PZQ by repeated washing, eggs were
allowed to hatch in water.
M: miracidium, UE: unhatched eggs, ( ): % hatched
* Differences were statistically significant (chi square, p < 0. 01).
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DISCUSSION
Since ova of S. haematobium take several days to pass through the bladder wall into
urine (Belding, 1965), the eggs examined in this study were evidently those which had
already been deposited in the venules of the bladder at the time of treatment. The present
study, therefore, was successfully designed to examine the effect of PZQ on the eggs of S.
haematobium in vivo. The present study revealed that the hatching of eggs excreted after
treatment was inhibited. It is a growing belief that active miracidia is responsible for
breakage of the eggshell (Samuelson et aL, 1984; Katsumata et al., 1988; Katsumata et al.,
1989). It would appear that PZQ has injurious effects upon the miracidia enclosed within the
eggshell in vivo.
When a single oral dose of 40 mg/kg body weight of PZQ was given the healthy
volunteers, the maximumplasma concentration of PZQ reached 0.7 //g/ml 3 hr later, and the
high plasma concentration of PZQ (over 0.1 jwg/ml) was observed for 24 hr after administra-
tion of PZQ (Mandour efaL, 1990). The eggs examined in our study, therefore, were pro-
bably exposed to the high concentration of PZQ (over 0.1 /*g/ml) for several hours. The
result of in vivo study was strongly supported by the results of in vitro experiments. When
the eggs were incubated in PBS containing PZQ at a concentration of 0.1 ^g/ml for one
hour, the hatching of the eggs was inhibited.
Andrew (1978) reported the fact that in vivo PZQ inhibited hatching of S. mansoni
miracidia for 24 hr after administration of 500 mg/kg to infected mice. Interestingly enough,
the eggs passed after 48 hr hatched normally and were infective to Biomphalaria glabrata
snails. In our study, the hatchability of the eggs excreted by patients 48 hr after treatment
with PZQ was likely to recover partially. PZQ-inhibited hatching of the eggs of S.
haematobium may be temporary in man as in a case of S. mansoni-mouse model, the in-
hibitory action of PZQ may be longer in man than in mice though.
It has been well known that the patients with urinary schistosomiasis excretes eggs for
several months after treatment (McMahon and Kolstrup, 1979). Doehring et al. (1985)
reported that many viable eggs were excreted by the patients during the initial 5 days after
treatment with PZQ, the hatchability of the eggs was not examined though. The present
study revealed that the hatchability of the eggs excreted by the patients treated with PZQ
was inhibited, even if the inhibitory action of PZQ would be temporary. The majority of the
patients treated with PZQ can be expected to contribute little to transmission of disease im-
mediately after treatment with PZQ.
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